SOCS1 and systemic lupus erythematosus: investigated the activation status of the IFN-γ signaling pathway in F1 mice with systemic lupus erythematosus (New Zealand-black × New Zealand-white) and found that the absence of SOCS1 led to impaired IFN-γ signaling, thereby exacerbating disease progression.